Results 1 to 10 of about 51,995 (213)

Pharmacoeconomics [PDF]

Macedonian Journal of Medical Sciences, 2013
Aim: The aim of this review was to provide an overview of the terminology, technology and methodology of pharmacoeconomic evaluations. The choice is made because there is small number of reviews on this subject in Macedonia, and also because of the subject actuality.Methods: There are four common types of methods of cost-outcomes economic evaluations ...
Marc A. Darst, Jennifer Reddan, Ashley N. Feneran   +2 more
  +7 more sources

A cross-sectional study of awareness, knowledge, and attitude in pharmacoeconomics related to antibiotic usage in medical postgraduate students

National Journal of Physiology, Pharmacy and Pharmacology, 2023
Background: Pharmacoeconomics is one of the burgeoning branch of pharmacology. In the scenario of popping up of various numbers of pharmaceutical companies the prices of various drugs especially antibiotics is varied and this study will help to decrease ...
Asha Latha Muppur, Sailaja Konda N V S R P L, Padmavathi D, Vasundra Devi B   +3 more
doaj   +1 more source

Perceptions of and Preparedness for the Application of Pharmacoeconomics in Practice, among Final Year Bachelor of Pharmacy Students in South Africa: A National Cross-Sectional Study

Pharmacy, 2023
For the improvement of access to health, many countries including South Africa, have adopted universal healthcare. However, this requires skills to apply health technology assessments for the facilitation of investment decisions.
Carlien Schmidt, Moliehi Matlala, Brian Godman, Amanj Kurdi, Johanna C. Meyer   +4 more
doaj   +1 more source

Pharmacoeconomics

YAKUGAKU ZASSHI, 2003
AbstractFor Abstract see ChemInform Abstract in Full Text.
Joseph Heyse, John Cook, Michael Drummond   +2 more
  +6 more sources

Comparative effectiveness of neutralising monoclonal antibodies in high risk COVID-19 patients: a Bayesian network meta-analysis

Scientific Reports, 2022
The purpose of this work was to review and synthesise the evidence on the comparative effectiveness of neutralising monoclonal antibody (nMAB) therapies in individuals exposed to or infected with SARS-CoV-2 and at high risk of developing severe COVID-19.
David McConnell, Marie Harte, Cathal Walsh, Desmond Murphy, Alistair Nichol, Michael Barry, Roisin Adams   +6 more
doaj   +1 more source

Cost analysis of the use of botulinum toxin type A in Spain [PDF]

Farmacia Hospitalaria, 2014
Objective: To estimate treatment costs of blepharospasm, cervical dystonia(CD), upper limb spasticity (ULS) and spasticity in children withcerebral palsy (SCCP) with botulinum neurotoxin type A (BoNT-A) inSpain.
F. de Andrés-Nogales, A. Morell, J. Aracil, C. Torres, I. Oyagüez, M. A. Casado   +5 more
doaj   +1 more source

P:11 – Pharmacoeconomics [PDF]

, 2000
Therophilus javanus is a koinobiont, solitary larval endoparasitoid currently being considered as a biological control agent against the pod borer Maruca vitrata, a devastating cowpea pest causing 20-80% crop losses in West Africa.
Aboubakar Souna, Djibril, Bokonon-Ganta, Aimé, Cusumano, Antonino, Pittendrigh, Barry Robert, Ravallec, Marc, Tamò, Manuele, Volkoff, Anne Nathalie   +6 more
core   +16 more sources

Cost-effectiveness and potential budget impact of non-pharmacological interventions for early management in prehypertensive people: an economic evaluation for China

BMC Public Health, 2023
Background Non-pharmacological interventions (NPIs) could be considered in the early management of prehypertensive population. This study aimed to evaluate the potential cost-effectiveness of NPIs and the budget impact of implementing NPIs on ...
Leyi Liang, Taihang Shao, Hao Li, Mingye Zhao, Wenxi Tang   +4 more
doaj   +1 more source

A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX‑EMD Study [PDF]

, 2020
Background The clinical and economic management of retinal diseases has become more complex following the introduction of new intravitreal treatments. Multicriteria decision analysis (MCDA) offers the potential to overcome the challenges associated with ...
Casado, Miguel Ángel, Cervera, Enrique, de Andrés‑Nogales, Fernando, García Layana, Alfredo, Ignacio García, Emilio Francisco, Llorente, Iñaki, Martínez Olmos, José, Martínez Sesmero, José Manuel, Martínez, Mercedes, Mur, Carlos, Ortiz, Pere, Peralta, Gemma, Poveda, José Luis, Rodríguez Maqueda, Mariano, Ruiz Moreno, José María, Trillo, José Luis, Udaondo, Patricia, Zarranz Ventura, Javier, Zulueta, Jacinto, Álvarez, Eloísa   +19 more
core   +3 more sources

PHARMACOECONOMICS AS A TOOL TO ENHANCE EFFICENCY OF HEALTH CARE SERVICES

Ринкова економіка: сучасна теорія і практика управління, 2017
Pharmacoeconomics identifies, measures, and compares the costs and consequences of drug therapy to health care systems and society. This article discusses the principles and methods of pharmacoeconomics and how they can be applied to clinical pharmacy ...
Denys Zakrytov, Navneet Kaur
doaj   +1 more source